Celgene competitorsClear all

Celgene's top competitors include BioNTech, Sanofi, Idorsia, Amgen, Gilead Sciences and Regeneron Pharmaceuticals.
Celgene
Celgene
Celgene is a biopharmaceutical company developing therapies for the treatment of cancer and inflammatory diseases.
BioNTech
BioNTech
BioNTech is biopharmaceutical company pioneering the development of individualized therapies for cancer and other diseases.
Sanofi
Sanofi
Sanofi is a global healthcare company engaged in the research, development, manufacture, and marketing of therapeutic solutions.
Idorsia
Idorsia
Idorsia, a biopharmaceutical company, discovers, develops, and commercializes drugs for unmet medical needs.
Amgen
Amgen
Amgen (formerly known as Applied Molecular Genetics) is a biotech company discovering, developing, manufacturing, and delivering human therapeutics products.
Gilead Sciences
Gilead Sciences
Gilead Sciences is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of innovative medicines.
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals is a biopharmaceutical company that develops, manufactures, and markets medicines.
Founding Date
Founding Date
1986
Founding Date
2008
Founding Date
2004
Founding Date
2017
Founding Date
1980
Founding Date
1987
Founding Date
1988
Type
Type
Subsidiary
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Summit, US HQ
Singapore, SG
Boudry, CH
Locations
Mainz, DE HQ
Halle (Saale), DE
Idar Oberstein, DE
Marburg, DE
Neuried, DE
Planegg, DE
Cambridge, US
see more
Locations
Paris, FR HQ
Macquarie Park, AU
Wien, AT
Dhaka, BD
Brussel, BE
Geel, BE
Zaventem, BE
see more
Locations
Allschwil, CH HQ
Shanghai, CN
Lörrach, DE
Chiyoda City, JP
Locations
Thousand Oaks, US HQ
Hydra, DZ
Vicente López, AR
Kew, AU
North Ryde, AU
Wien, AT
Machelen, BE
see more
Locations
Foster City, US HQ
Abb, AR
Melbourne, AU
Wien, AT
Machelen, BE
São Paulo, BR
Edmonton, CA
see more
Locations
Tarrytown, US HQ
Dublin, IE
Limerick, IE
Uxbridge, GB
Bernards, US
Rensselaer, US
Sleepy Hollow, US
see more
Employees
Employees
8,85219% increase
Employees
1,30018% increase
Employees
100,4094% decrease
Employees
8007% increase
Employees
23,4009% increase
Employees
11,8007% increase
Employees
8,1009% increase
Valuation ($)
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
139.5 b
Valuation ($)
86.6 b
Valuation ($)
56 b
Twitter followers
Twitter followers
26.8 k
Twitter followers
57.8 k
Twitter followers
141.1 k
Twitter followers
1 k
Twitter followers
99.6 k
Twitter followers
67.9 k
Twitter followers
28.4 k
Number of tweets (last 30 days)
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
10
Number of tweets (last 30 days)
46
Number of tweets (last 30 days)
31
Number of tweets (last 30 days)
97
Number of tweets (last 30 days)
19
Number of tweets (last 30 days)
53
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
172.2
Average likes per tweet (last 30 days)
22.2
Average likes per tweet (last 30 days)
7.5
Average likes per tweet (last 30 days)
11.9
Average likes per tweet (last 30 days)
25.3
Average likes per tweet (last 30 days)
17.4
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
97.83%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
95.88%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
88.68%
Alexa Website Rank
Alexa Website Rank
N/A
Alexa Website Rank
250585
Alexa Website Rank
123373
Alexa Website Rank
158246
Alexa Website Rank
200877
Alexa Website Rank
112610
Alexa Website Rank
183060
Employee Rating
Employee Rating
4
Employee Rating
3.5
Employee Rating
3.3
Employee Rating
3.9
Employee Rating
4
Employee Rating
3.8
Employee Rating
4

Financial

Revenue (est.)
Revenue (est.)
$15.3b (FY, 2018)
Revenue (est.)
N/A
Revenue (est.)
€36b (FY, 2020)
Revenue (est.)
CHF23.8m (FY, 2019)
Revenue (est.)
$25.4b (FY, 2020)
Revenue (est.)
$24.7b (FY, 2020)
Revenue (est.)
$8.5b (FY, 2020)
Cost of goods
Cost of goods
$587m (FY, 2018)
Cost of goods
€59.3m (FY, 2020)
Cost of goods
€12.2b (FY, 2020)
Cost of goods
N/A
Cost of goods
$6.2b (FY, 2020)
Cost of goods
$4.6b (FY, 2020)
Cost of goods
N/A
Gross profit
Gross profit
$14.7b (FY, 2018)
Gross profit
N/A
Gross profit
€25.2b (FY, 2020)
Gross profit
N/A
Gross profit
$19.3b (FY, 2020)
Gross profit
$20.1b (FY, 2020)
Gross profit
N/A
Net income
Net income
$4b (FY, 2018)
Net income
€15.2m (FY, 2020)
Net income
€12.4b (FY, 2020)
Net income
(CHF494.6m) (FY, 2019)
Net income
$7.3b (FY, 2020)
Net income
$89m (FY, 2020)
Net income
$3.5b (FY, 2020)

Operating

Countries
Countries
N/A
Countries
N/A
Countries
N/A
Countries
N/A
Countries
100 (FY, 2019)
Countries
35 (FY, 2019)
Countries
N/A
Patents (EU)
Patents (EU)
N/A
Patents (EU)
N/A
Patents (EU)
N/A
Patents (EU)
N/A
Patents (EU)
21 (FY, 2019)
Patents (EU)
N/A
Patents (EU)
11 (FY, 2019)
Patents (US)
Patents (US)
N/A
Patents (US)
45 (Oct, 2019)
Patents (US)
N/A
Patents (US)
N/A
Patents (US)
34 (FY, 2019)
Patents (US)
650 (Dec, 2020)
Patents (US)
21 (FY, 2019)
Phase I Trials Products
Phase I Trials Products
N/A
Phase I Trials Products
8 (Oct, 2019)
Phase I Trials Products
N/A
Phase I Trials Products
N/A
Phase I Trials Products
22 (FY, 2019)
Phase I Trials Products
N/A
Phase I Trials Products
N/A
Phase I Trials Products (Oncology)
Phase I Trials Products (Oncology)
N/A
Phase I Trials Products (Oncology)
N/A
Phase I Trials Products (Oncology)
12 (FY, 2020)
Phase I Trials Products (Oncology)
N/A
Phase I Trials Products (Oncology)
N/A
Phase I Trials Products (Oncology)
7 (FY, 2019)
Phase I Trials Products (Oncology)
N/A
Phase II Trials Products
Phase II Trials Products
N/A
Phase II Trials Products
1 (Oct, 2019)
Phase II Trials Products
N/A
Phase II Trials Products
N/A
Phase II Trials Products
4 (FY, 2019)
Phase II Trials Products
N/A
Phase II Trials Products
N/A
Phase II Trials Products (Oncology)
Phase II Trials Products (Oncology)
N/A
Phase II Trials Products (Oncology)
N/A
Phase II Trials Products (Oncology)
6 (FY, 2020)
Phase II Trials Products (Oncology)
N/A
Phase II Trials Products (Oncology)
N/A
Phase II Trials Products (Oncology)
2 (FY, 2019)
Phase II Trials Products (Oncology)
N/A
Phase III Trials Products
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
14 (Feb, 2020)
Phase III Trials Products
27 (FY, 2019)
Phase III Trials Products
N/A
Products
Products
N/A
Products
N/A
Products
N/A
Products
N/A
Products
N/A
Products
24 (FY, 2019)
Products
7 (FY, 2019)
Projects in R&D Pipeline
Projects in R&D Pipeline
N/A
Projects in R&D Pipeline
N/A
Projects in R&D Pipeline
91 (FY, 2019)
Projects in R&D Pipeline
12 (FY, 2019)
Projects in R&D Pipeline
N/A
Projects in R&D Pipeline
N/A
Projects in R&D Pipeline
N/A

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
$ 1.4b
Total funding raised
$ 310m
Total funding raised
N/A
Total funding raised
$ 175.5m
Total funding raised
N/A
Total funding raised
$ 8.9m
For sources of this data, please see the company profile

View company profiles

BioNTech
HQ
Mainz, DE
Employees
1,300↑ 18% increase

BioNTech is biopharmaceutical company pioneering the development of individualized therapies for cancer and other diseases.

View company
Sanofi
HQ
Paris, FR
Employees
100,409↓ 4% decrease

Sanofi is a global healthcare company engaged in the research, development, manufacture, and marketing of therapeutic solutions.

View company
Idorsia
HQ
Allschwil, CH
Employees
800↑ 7% increase

Idorsia, a biopharmaceutical company, discovers, develops, and commercializes drugs for unmet medical needs.

View company
Amgen
HQ
Thousand Oaks, US
Employees
23,400↑ 9% increase

Amgen (formerly known as Applied Molecular Genetics) is a biotech company discovering, developing, manufacturing, and delivering human therapeutics products.

View company